Medios AG (OTCMKTS:MEDOF) Short Interest Update

Medios AG (OTCMKTS:MEDOF) was the recipient of a significant decrease in short interest in September. As of September 15th, there was short interest totaling 66 shares, a decrease of 88.2% from the August 31st total of 561 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Medios in a research report on Thursday, August 13th. One research analyst has rated the stock with a Buy rating, Based on data from MarketBeat, Medios currently has an average rating of “Buy”.

Medios Price Performance

Medios stock remained flat at C$13.64 during mid-day trading on Friday. Medios has a 52-week low of C$13.64 and a 52-week high of C$13.64. The business has a fifty day moving average price of C$13.64 and a 200 day moving average price of C$13.64.

Medios Company Profile

Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany. It operates through Pharmaceutical Supply and Patient-Specific Therapies segments. The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases. The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies. This segment includes cytostatic infusion preparations, antibody therapies, virostatic and antibiotic medications, parenteral nutrition solutions, and investigational medicinal products.